| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Ophthalmic Genetics and Clinical Services Branch, National Eye Institute and the 2 National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; and the 3 Foundation Fighting Blindness, Hunt Valley, Maryland.
PURPOSE. To investigate the role of abnormal lipid metabolism in Bietti crystalline dystrophy.
METHODS. Cultured human lymphocytes and fibroblasts from patients with Bietti crystalline dystrophy (BCD) were incubated in the presence of [14C]18:3n-3 or [14C]18:2n-6. Incorporation into the cellular lipid pools and further metabolism by desaturation or elongation were monitored by thin-layer chromatography and HPLC. Results were compared with those in normal control subjects and patients with Wolman disease (WD).
RESULTS. Pulse–chase experiments with labeled fatty acids in all groups showed that, after 1 hour, radioactivity was largely confined to the triacylglyceride (TG) and choline phosphoglyceride (CPG) pools. However, after several hours, radioactivity was transferred from the TG and CPG pools, some going to the serine and ethanolamine phosphoglyceride (SPG and EPG) pools. Fibroblasts from all groups showed direct transfer of fatty acids (FAs) into CPG and EPG. Incorporation of labeled FAs into the EPG pool paralleled extensive desaturation and elongation of 18:2n-6 to 22:5n-6 and 18:3n-3 to 22:6n-3. Fibroblasts from patients with WD (a lysosomal acid lipase deficiency characterized by excessive lipid accumulation), showed higher incorporation of 18:2n-6 into TGs than did normal or BCD fibroblasts. Conversely, fibroblasts from patients with BCD showed lower conversion of 18:3n-3, but not of 18:2n-6, into polyunsaturated FAs (PUFAs) than those of normal subjects or patients with WD. This was true for total FAs, CPGs, and EPGs. Similar results were found in both fibroblasts and lymphocytes; however, unlike fibroblasts, lymphocytes from normal subjects showed similar levels of incorporation of FAs into EPGs and CPGs. In contrast, incorporation of 18:3n-3 into EPGs was decreased in lymphocytes from patients with BCD.
CONCLUSIONS. BCD is characterized by a lower than normal conversion of FA precursors into n-3 PUFA, whereas there is a higher than normal level of n-6 and n-3 FAs incorporation into TGs in cells from patients with WD. These findings raise the possibility that abnormal lipid metabolism associated with BCD is the result of deficient lipid binding, elongation, or desaturation in contrast to the lysosomal acid lipase deficiency found in Wolman disease.
This article has been cited by other articles:
|
|
 |
|
  T. Y. Y. Lai, K.-O. Chu, K.-P. Chan, T.-K. Ng, G. H. F. Yam, D. S. C. Lam, and C.-P. Pang Alterations in Serum Fatty Acid Concentrations and Desaturase Activities in Bietti Crystalline Dystrophy Unaffected by CYP4V2 Genotypes Invest. Ophthalmol. Vis. Sci., February 1, 2010; 51(2): 1092 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. D. Bezemer, L. A. Bare, C. J. M. Doggen, A. R. Arellano, C. Tong, C. M. Rowland, J. Catanese, B. A. Young, P. H. Reitsma, J. J. Devlin, et al. Gene Variants Associated With Deep Vein Thrombosis JAMA, March 19, 2008; 299(11): 1306 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Y. Y. Lai, T. K. Ng, P. O. S. Tam, G. H. F. Yam, J. W. S. Ngai, W.-M. Chan, D. T. L. Liu, D. S. C. Lam, and C. P. Pang Genotype Phenotype Analysis of Bietti's Crystalline Dystrophy in Patients with CYP4V2 Mutations Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5212 - 5220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Y. C. Lee, A. H. C. Koh, T. Aung, V. H. K. Yong, K. Yeung, C.-L. Ang, and E. N. Vithana Characterization of Bietti Crystalline Dystrophy Patients with CYP4V2 Mutations Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3812 - 3816. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
